Official Full Name |
Recombinant Human BCA-1/CXCL13 (rHuBCA-1/CXCL13) |
Squence |
 |
Amino Acid Sequence |
VLEVYYTSLR CRCVQESSVF IPRRFIDRIQ ILPRGNGCPR KEIIVWKKNK SIVCVDPQAE WIQRMMEVLR KRSSSTLPVP VFKRKIP |
Synonyms |
Angie, B lymphocyte chemoattractant, CXC chemokine BLC, Small-inducible cytokine B13 |
Accession Number |
O43927 |
GeneID |
10563 |
Summary |
|
Source |
Escherichia coli. |
Molecular Weight |
Approximately 10.3 kDa, a single non-glycosylated polypeptide chain containing 87 amino acids. |
Biological Activity |
Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human B cells is in a concentration range of 1.0-10 ng/ml. |
Appearance |
Sterile filtered white lyophilized (freeze-dried) powder. |
Formulation |
Lyophilized from a 0.2 um filtered concentrated solution in 20 mM PB, pH 7.4, 100 mM NaCl. |
Endotoxin |
Less than 1 EU/ug of rHuBCA-1/CXCL13 as determined by LAL method. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
References |
1. Legler DF, Loetscher M, Roos RS, et al. 1998. J Exp Med. 187:655-60.2. Gunn MD, Ngo VN, Ansel KM, et al. 1998. Nature. 391:799-803.3. Ansel KM, Harris RB, Cyster JG. 2002. Immunity. 16:67-76.4. Ansel KM, Ngo VN, Hyman PL, et al. 2000. Nature. 406:309-14. |
SDS-PAGE |
 |
Safety Data Sheet (SDS) Download |
Click to download |
Technical Data Sheet (TDS) Download |
Click to download |